Arcus Biosciences, Inc.(RCUS)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | Azoy Alexander Chief Accounting Officer | Sale | -2,562 | -6.08%39,581 | $25.77 | $66,024 | View SEC filing | |
| 2026-05-12 | Goeltz II Robert C. Chief Financial Officer | Sale | -7,763 | -8.45%84,161 | $25.63 | $198,966 | View SEC filing | |
| 2026-01-07 | Jaen Juan C. President | Sale | -31,823 | -3.34%922,240 | $21.41 | $681,342 | View SEC filing | |
| 2026-01-02 | Goeltz II Robert C. Chief Financial Officer | Sale | -6,552 | -8.80%67,924 | $23.38 | $153,186 | View SEC filing | |
| 2025-12-18 | Markus Richard Chief Medical Officer | Sale | -9,546 | -12.70%65,647 | $22.01 | $210,144 | View SEC filing | |
| 2025-12-18 | Tang Carolyn C. General Counsel | Sale | -14,468 | -10.39%124,734 | $22.01 | $318,496 | View SEC filing | |
| 2025-12-18 | Azoy Alexander Chief Accounting Officer | Sale | -8,832 | -32.28%18,531 | $22.13 | $195,434 | View SEC filing | |
| 2025-12-18 | Jarrett Jennifer Chief Operating Officer | Sale | -21,208 | -9.90%193,024 | $22.01 | $466,870 | View SEC filing | |
| 2025-12-18 | Goeltz II Robert C. Chief Financial Officer | Sale | -12,662 | -14.53%74,476 | $22.01 | $278,739 | View SEC filing | |
| 2025-12-18 | Jaen Juan C. President | Sale | -21,208 | -5.78%346,012 | $22.01 | $466,870 | View SEC filing | |
| 2025-12-18 | ROSEN TERRY J Chief Executive Officer | Sale | -54,691 | -2.43%2,194,809 | $22.01 | $1,203,959 | View SEC filing | |
| 2025-12-05 | Jaen Juan C. President | Sale | -82,997 | -8.00%954,063 | $24.71 | $2,050,599 | View SEC filing | |
| 2025-12-01 | Azoy Alexander Chief Accounting Officer | Sale | -1,900 | -6.49%27,363 | $26.00 | $49,400 | View SEC filing | |
| 2025-11-26 | Goeltz II Robert C. Chief Financial Officer | Sale | -5,000 | -5.43%87,138 | $25.00 | $125,000 | View SEC filing | |
| 2025-11-19 | Jaen Juan C. President | Sale | -50,000 | -4.60%1,037,060 | $20.26 | $1,012,764 | View SEC filing | |
| 2025-11-12 | Jarrett Jennifer Chief Operating Officer | Sale | -50,291 | -19.01%214,232 | $18.97 | $954,066 | View SEC filing | |
| 2025-11-03 | Jaen Juan C. President | Sale | -4,314 | -0.40%1,087,060 | $20.32 | $87,650 | View SEC filing | |
| 2025-10-30 | Jaen Juan C. President | Sale | -96,859 | -8.15%1,091,374 | $20.76 | $2,010,578 | View SEC filing | |
| 2025-10-29 | Goeltz II Robert C. Chief Financial Officer | Sale | -5,000 | -5.15%92,138 | $20.00 | $100,000 | View SEC filing | |
| 2025-10-08 | Jarrett Jennifer Chief Operating Officer | Sale | -50,292 | -5.51%214,232 | $14.92 | $750,412 | View SEC filing | |
| 2025-09-30 | Azoy Alexander Chief Accounting Officer | Sale | -2,831 | -9.38%27,363 | $13.00 | $36,803 | View SEC filing | |
| 2025-09-05 | Azoy Alexander Chief Accounting Officer | Sale | -1,579 | -4.97%30,194 | $11.88 | $18,758 | View SEC filing | |
| 2025-02-27 | KANEKO YASUNORI Director | Purchase | +20,000 | +238.10%28,400 | $10.06 | $201,200 | View SEC filing | |
| 2025-02-27 | ROSEN TERRY J Chief Executive Officer | Purchase | +19,800 | +0.78%2,554,160 | $10.18 | $201,465 | View SEC filing | |
| 2025-02-20 | GILEAD SCIENCES, INC. 10% Owner | Purchase | +1,363,636 | +4.54%31,424,760 | $11.00 | $14,999,996 | View SEC filing |
1-25 of 98